Supplemental MR imaging for women at higher risk for breast cancer is not done frequently enough.
More interval breast cancers detected when screening mammography recall rates are low.
Magnetic resonance imaging screening is not consistent with guidelines for women at low to moderate risk for breast cancer.
Screening performance with MR imaging and mammography depends on breast cancer risk category.
An MRI procedure that does not use contrast agents may reduce the number of unnecessary breast biopsies.
Pretreatment MRI shows kurtosis may be promising biomarker for identification of triple-negative breast cancer.
Breast MRI in pregnancy-associated breast cancer may change the surgical management of patients.
Sub-harmonic aided pressure estimation and sub-harmonic imaging can correctly predict responses after 10% chemotherapy completion.
Breast cancers detected by screening mammography do not spontaneously disappear.
Additional MR screening helps identify previously undiagnosed breast cancers in women with average lifetime risk.